VeriSIM Life Earns Frost & Sullivan Competitive Strategy Leadership Award for Best Practices in AI-enabled Preclinical Development Industry

VeriSIM Life eliminates waste and inaccuracy, accelerates preclinical development, and lowers costs and risks when converting drug candidates to clinical trials, and brings life-saving drugs

Related Keywords

United States ,America ,American ,Dwain Schenck ,Aarti Chitale ,Jo Varshney ,Kristen Moore ,Kostenloser Wertpapierhandel ,Tanja Dowe ,Frost Sullivan Best Practices Research Analyst ,Debiopharm Innovation Fund ,America Competitive Strategy Leadership ,Translational Index ,Sullivan Senior Industry Analyst ,Investigational New Drug ,Natalia Casanovas ,Sullivan Best Practices Research ,American Competitive Strategy Leadership Award ,Debiopharm Innovation ,Sullivan Best Practices ,Mega Trends ,Verisim ,Life ,Warns ,Frost ,Sullivan ,Ompetitive ,Strategy ,Leadership ,Award ,Pest ,Practices ,Nabled ,Reclinical ,Development ,Industry ,